Company intelligence / Profile preview

Langzhi Group Shuangren Pharmaceutical

Jinzhong, Shanxi, Chinalangzhi.com.cn ↗
Ownership
Private
Employees
~2000
Development stage
Other
01

Overview

Langzhi Group Shuangren Pharmaceutical is a Chinese pharmaceutical enterprise that integrates the research, development, and production of chemical drugs and Traditional Chinese Medicine (TCM). Based in Shanxi Province, the company serves as a key manufacturing and commercial arm of the Langzhi Group, focusing on high-demand therapeutic areas including cardiovascular, cerebrovascular, and respiratory health. Its product portfolio features a mix of modern chemical formulations, such as widely used cold and flu treatments, alongside standardized TCM products. The company operates large-scale GMP-certified facilities and is recognized for its "Shuangren" brand, which maintains a significant presence in both the Chinese domestic retail and hospital markets. Langzhi Group emphasizes a "dual-wheel" strategy, combining modern pharmacological innovation with traditional herbal expertise to address chronic and acute conditions.

Therapeutic areas
CardiovascularInfectious Diseases
Modalities
Small moleculeTraditional Chinese Medicine
Industry
Biotech
02

Drug pipeline

6 assets

Zhizhu Kuanzhong

4

5 more assets in the full pipeline.

Beyond the preview

Go deeper on Langzhi Group Shuangren Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Langzhi Group Shuangren Pharmaceutical.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call